| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $24.51B | $24.25B | $24.12B |
| YoY Revenue Growth % | +1.1% | +0.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $9.85B | $9.71B | $9.08B |
| Operating Margin % | 40.2% | 40.1% | 37.7% |
| Net Income (GAAP) | $7.14B | $6.75B | $6.38B |
| EBITDA (Normalized) | $12.88B | $12.47B | $9.95B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $9.29B | $9.35B | $8.38B |
| Capital Expenditures (CapEx) | $3.79B | $3.45B | $1.09B |
| Free Cash Flow (FCF) | $5.50B | $5.89B | $7.29B |
| FCF Margin % | 22.4% | 24.3% | 30.2% |
| Return on Invested Capital (ROIC %) | 19.3% | 19.8% | 12.0% |
| Cash & Short-Term Equivalents | $1.27B | $1.02B | — |
| Total Debt (Short + Long Term) | $23.05B | $22.87B | $23.09B |
| Total Stockholders' Equity | $18.47B | $16.89B | $47.37B |